Device Lesion Access

Glidesheath Slender

Payments companies reported to CMS as associated with Glidesheath Slender. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.0Massociated payments (2023-2025)
1,730clinicians with associated payments
2companies reporting

By year

2023 $339K
2024 $359K
2025 $308K

Payments reported as associated with Glidesheath Slender, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $462K
Interventional Cardiology $276K
Vascular Surgery $102K
Cardiovascular Disease $51K
Diagnostic Radiology $48K
Internal Medicine $11K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Glidesheath Slender

These are the largest totals companies reported as associated with Glidesheath Slender. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Marcelo Guimaraes Charleston, SC Vascular & Interventional Radiology $91,259.54
Amit Srivastava Edgewood, KY Interventional Cardiology $86,193.96
Sameh Sayfo Plano, TX Interventional Cardiology $65,975.32
Justin Mcwilliams Los Angeles, CA Vascular & Interventional Radiology $50,126.52
Edvard Skripochnik Bronx, NY Vascular Surgery $44,552.14
Neil Resnick Worcester, MA Vascular & Interventional Radiology $36,931.41
Ari Isaacson Chapel Hill, NC Vascular & Interventional Radiology $25,823.08
Srinivasa Potluri Plano, TX Interventional Cardiology $24,079.92
William Julien Coconut Creek, FL Vascular & Interventional Radiology $22,873.72
Mark Lessne Charlotte, NC Diagnostic Radiology $22,632.90

Prescribed Glidesheath Slender?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.